NCT01590069View on ClinicalTrials.gov

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 28, 2012

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic OsteosarcomaMetastatic Renal Cell CancerSarcomaStage IV Cutaneous Melanoma AJCC v6 and v7Stage IV Osteosarcoma AJCC v7Stage IV Renal Cell Cancer AJCC v7
Interventions
BIOLOGICAL

Aerosolized Aldesleukin

Breathe aerosolized aldesleukin

OTHER

Laboratory Biomarker Analysis

Optional correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER